Testing effectiveness (Phase 2)Active Not RecruitingNCT01991379
What this trial is testing
MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Memorial Sloan Kettering Cancer Center 75